Abstract:Objective: Because of its potent pro-inflammatory properties, interleukin-17 (IL-17) contributes to the pathogenesis of various inflammatory diseases. This study explored the effects of IL-17 on osteoclastogenesis in an osteoclast monoculture and osteoblast-osteoclast co-culture system, as tools to investigate the molecular mechanisms underlying the interactions between osteoclastogenesis and autophagy. Methods: Various ratios of calvarial osteoblasts (OB) and osteoclast precursor cells (mouse macrophage cell line RAW264.7, hereinafter referred to as OC) were tested. Tartrate-resistant acid phosphatase (TRAP) staining was used to detect the optimum osteoblasts:osteoclasts ratio. IL-17 was added to the co-culture system to test its effects on multinucleated osteoclast formation and osteoclast-related proteins. We assessed the effects of IL-17 on receptor activator of nuclear factor-kappa B ligand (RANKL) expression in osteoblasts, and determined if IL-17 alone could modulate osteoclast formation in an osteoclast monoculture. Administration of exogenous RANKL combined with IL-17 was employed to stimulate RAW264.7 cells osteoclastogenesis and to determine production of osteoclasts and autophagy-related proteins. We knocked down Beclin1 expression in RAW264.7 cells and examined the expression of autophagy-related and osteoclast-related proteins in RAW264.7 cells and the co-culture system, and the TAK1-binding protein 3 (TAB3)/ extracellular signal regulated kinase (ERK) pathway. Results: A ratio of 20 OB : 1 OC yielded the highest rate of osteoclast formation. Low IL-17 concentrations increased osteoclastogenesis in co-cultures significantly, but high levels of IL-17 had the opposite effect. IL-17 alone could not induce formation of TRAP+ multinucleated cells in RAW264.7 cells. Low IL-17 concentrations promoted osteoclast differentiation and autophagy in RAW264.7 cells induced by exogenous RANKL, but high IL-17 concentrations inhibited this process. Knockdown of Beclin1 reversed the enhanced effects of 0.1 ng/mL IL-17 on osteoclastogenesis and autophagy in RAW264.7 cells. The TAB3/ERK pathway was also blocked after autophagy inhibition. Conclusion: In the co-culture model used in this study, a ratio of 20 OB:1 OC proved to be the optimal ratio to facilitate osteoclast formation. IL-17 regulated RANKL-induced osteoclastogenesis via autophagy. The Beclin1/TAB3/ERK pathway was involved in osteoclast autophagy.

Il-23 Promotes Osteoclast Formation by Up-Regulation of Receptor Activator of Nf-Kappa B (rank) Expression in Myeloid Precursor Cells

Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages.

TRAF6/ERK/p38 Pathway is Involved in Interleukin-17-mediated Autophagy to Promote Osteoclast Precursor Cell Differentiation.

AB0152 IL-23 INDUCES OSTEOCLASTS TO EXPRESS PRO-OSTEOGENIC FACTORS RATHER THAN ANTI-OSTEOGENIC FACTORS

Crosstalk among IL-23 and DNAX Activating Protein of 12 Kda–dependent Pathways Promotes Osteoclastogenesis

Crosstalk among interleukin 23 and DNAX activating protein 12-dependent pathways promotes osteoclastogenesis

Expression Profile of Osteoclasts Following the Stimulation with Interleukin-23 in Mice

Interleukin-21 Promotes Osteoclastogenesis in RAW264.7 Cells Through the PI3K/AKT Signaling Pathway Independently of RANKL.

IL-23, but not IL-12, plays a critical role in inflammation-mediated bone disorders

Interleukin-23 Mediates Osteoclastogenesis in Collagen-Induced Arthritis by Modulating MicroRNA-223

Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo

Combination Of Il-6 And Sil-6r Differentially Regulate Varying Levels Of Rankl-Induced Osteoclastogenesis Through Nf-Kappa B, Erk And Jnk Signaling Pathways

Molecular Basis of Requirement of Receptor Activator of Nuclear Factor Κb Signaling for Interleukin 1-Mediated Osteoclastogenesis.

Il-23 Induces The Expression Of Pro-Osteogenic Factors In Osteoclasts

Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-κB, ERK and JNK signaling pathways

Different Modulatory Effects of IL-17, IL-22, and IL-23 on Osteoblast Differentiation

RANKL expression of primary osteoblasts is enhanced by an IL-17-mediated JAK2/STAT3 pathway through autophagy suppression

Interleukin-3 Plays Dual Roles in Osteoclastogenesis by Promoting the Development of Osteoclast Progenitors but Inhibiting the Osteoclastogenic Process

Class A Scavenger Receptor Exacerbates Osteoclastogenesis by an Interleukin-6-Mediated Mechanism through ERK and JNK Signaling Pathways

IL-17A regulates autophagy and promotes osteoclast differentiation through the ERK/mTOR/Beclin1 pathway

IL-18 Upregulates the Production of Key Regulators of Osteoclastogenesis from Fibroblast-Like Synoviocytes in Rheumatoid Arthritis